My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 86

2.

Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada.

Deniz HB, Ward A, Jaime Caro J, Alvarez P, Sadri H.

Curr Med Res Opin. 2009 Mar;25(3):617-26.PMID: 19232036 [PubMed - in process]Related articles

3.

Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Al-Khatib SM, Hellkamp AS, Lee KL, Anderson J, Poole JE, Mark DB, Bardy GH; scd-heft investigators.

J Cardiovasc Electrophysiol. 2008 Oct;19(10):1059-65. Epub 2008 May 9.PMID: 18479330 [PubMed - indexed for MEDLINE]Related articles

4.

Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy.

Gold MR, Ip JH, Costantini O, Poole JE, McNulty S, Mark DB, Lee KL, Bardy GH.

Circulation. 2008 Nov 11;118(20):2022-8. Epub 2008 Oct 27.PMID: 18955671 [PubMed - indexed for MEDLINE]Related articlesFree article

5.

Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome.

Boriani G, Rapezzi C, Diemberger I, Gonzini L, Gorini M, Lucci D, Sinagra G, Cooke RM, Di Pasquale G, Tavazzi L, Maggioni AP.

J Eval Clin Pract. 2009 Oct 27. [Epub ahead of print]PMID: 19874436 [PubMed - as supplied by publisher]Related articles

6.

Long-term follow-up of patients with indication for a implantable defibrillator for primary prevention of death.

Hadid C, Avellana P, Di Toro D, Gomez CF, Visser M, Prieto N.

Arq Bras Cardiol. 2008 May;90(5):311-5. English, Portuguese. PMID: 18516400 [PubMed - indexed for MEDLINE]Related articlesFree article

7.

Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C.

Arch Intern Med. 2009 Sep 14;169(16):1500-6.PMID: 19752408 [PubMed - indexed for MEDLINE]Related articles

8.

Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population.

Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT, Maggioni AP, Anand I, Poole-Wilson PA, Fishbein DP, Johnson G, Anderson J, Mark DB, Bardy GH.

Circulation. 2009 Sep 8;120(10):835-42. Epub 2009 Aug 24.PMID: 19704100 [PubMed - indexed for MEDLINE]Related articles

9.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.PMID: 18547499 [PubMed - indexed for MEDLINE]Related articlesFree article

10.

Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.

Johnson WD, Diaz RM, Flanders WD, Goodman M, Hill AN, Holtgrave D, Malow R, McClellan WM.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. Review.PMID: 18646068 [PubMed - indexed for MEDLINE]Related articles

11.

Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

Gula LJ, Klein GJ, Hellkamp AS, Massel D, Krahn AD, Skanes AC, Yee R, Anderson J, Johnson GW, Poole JE, Mark DB, Lee KL, Bardy GH.

Am Heart J. 2008 Dec;156(6):1196-200. Epub 2008 Nov 6.PMID: 19033019 [PubMed - indexed for MEDLINE]Related articlesFree article

12.

No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Blatt JA, Poole JE, Johnson GW, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Anderson J, Chung K, Wong WS, Mark DB, Lee KL, Bardy GH; SCD-HeFT Investigators.

J Am Coll Cardiol. 2008 Aug 12;52(7):551-6.PMID: 18687249 [PubMed - indexed for MEDLINE]Related articles

13.

Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial--a prospective pilot study.

de Bie MK, Lekkerkerker JC, van Dam B, Gaasbeek A, van Buren M, Putter H, van Erven L, Bax JJ, Schalij MJ, Rabelink TJ, Jukema JW.

Curr Med Res Opin. 2008 Aug;24(8):2151-7. Epub 2008 Jun 17.PMID: 18561878 [PubMed - indexed for MEDLINE]Related articles

14.

Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis.

Hallstrom AP, Wyse DG, McAnulty J; CAST; AVID.

J Interv Card Electrophysiol. 2008 Dec;23(3):159-66. Epub 2008 Sep 23.PMID: 18810620 [PubMed - indexed for MEDLINE]Related articles

15.

Evidence regarding clinical use of microvolt T-wave alternans.

Hohnloser SH, Ikeda T, Cohen RJ.

Heart Rhythm. 2009 Mar;6(3 Suppl):S36-44. Epub 2008 Oct 11.PMID: 19168396 [PubMed - indexed for MEDLINE]Related articles

16.

Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.

Chapa DW, Lee HJ, Kao CW, Friedmann E, Thomas SA, Anderson J, Bardy GH.

Am J Crit Care. 2008 Sep;17(5):443-52; quiz 453. Review.PMID: 18776000 [PubMed - indexed for MEDLINE]Related articlesFree article

17.

Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria?

Daugherty SL, Peterson PN, Wang Y, Curtis JP, Heidenreich PA, Lindenfeld J, Vidaillet HJ, Masoudi FA; NCDR.

Am Heart J. 2009 Aug;158(2):224-9.PMID: 19619698 [PubMed - indexed for MEDLINE]Related articles

18.

Implantable device therapy.

Goldenberg I, Moss AJ.

Prog Cardiovasc Dis. 2008 May-Jun;50(6):449-74. Review.PMID: 18474287 [PubMed - indexed for MEDLINE]Related articles

19.

Effect of fish oil on ventricular tachyarrhythmia in three studies in patients with implantable cardioverter defibrillators.

Brouwer IA, Raitt MH, Dullemeijer C, Kraemer DF, Zock PL, Morris C, Katan MB, Connor WE, Camm JA, Schouten EG, McAnulty J.

Eur Heart J. 2009 Apr;30(7):820-6. Epub 2009 Feb 4. Review.PMID: 19196720 [PubMed - indexed for MEDLINE]Related articles

20.

Effect of pacing for soft indications on mortality and heart failure in the dual chamber and VVI implantable defibrillator (DAVID) trial.

Kutalek SP, Sharma AD, McWilliams MJ, Wilkoff BL, Leonen A, Hallstrom AP, Kudenchuk PJ; DAVID Investigators.

Pacing Clin Electrophysiol. 2008 Jul;31(7):828-37.PMID: 18684279 [PubMed - indexed for MEDLINE]Related articles

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Find related data

Write to the Help Desk